Leerink Swann initiates coverage on Shire Pharma (Nasdaq: SHPGY) with an Overweight.

Leerink analyst says, "We believe the current ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE